세계의 심혈관 디바이스 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2032년)

The global demand for Cardiovascular Devices Market is presumed to reach the market size of nearly USD 96.93 Billion by 2032 from USD 50.18 Billion in 2023 with a CAGR of 7.59% under the study period 2024 - 2032.

Cardiovascular devices are designed to diagnose, monitor, treat, or manage conditions affecting the cardiovascular system, including the heart and blood vessels. These devices cover many products, such as implantable pacemakers, defibrillators, stents, catheters, cardiac monitors, and vascular grafts.

MARKET DYNAMICS

The increasing burden of cardiovascular diseases such as coronary artery disease, heart failure, and arrhythmias, driven by aging populations, sedentary lifestyles, and rising incidence of factors posing risks such as diabetes, obesity, and hypertension, has led to growing demand for diagnostic and therapeutic cardiovascular devices. These devices, including implantable cardiac monitors, pacemakers, defibrillators, stents, and catheters, play a critical role in diagnosing, treating, and managing various cardiovascular conditions, driving market adoption among patients, healthcare providers, and payers. Moreover, advancements in medical technology, such as robotic-assisted surgery, minimally invasive procedures, and remote monitoring systems, have expanded the capabilities and applications of cardiovascular devices, enabling safer, more precise, and less invasive treatment options for patients, driving market innovation and differentiation. Moreover, the growing emphasis on preventive cardiology, early detection, and personalized medicine has fueled demand for cardiovascular diagnostic devices such as electrocardiography (ECG) machines, echocardiography systems, and cardiac imaging modalities, driving market expansion. Furthermore, the increasing investment in research and development activities aimed at developing next-generation cardiovascular devices with enhanced safety, efficacy, and usability, regulatory approvals, and market launches of novel products and technologies are expected to drive further market growth and competitiveness.

Lastly, the impact of the COVID-19 pandemic on healthcare delivery, telemedicine adoption, and patient care pathways has accelerated the adoption of remote monitoring, digital health solutions, and home-based cardiovascular devices, driving market demand for innovative remote monitoring systems, wearable devices, and mobile health apps that enable continuous monitoring and management of cardiovascular conditions in real-time, further fueling market expansion and diversification. However, changes in healthcare policies, regulatory constraints, and competition from alternative treatment modalities may challenge the market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of cardiovascular devices. The growth and trends of cardiovascular devices industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the cardiovascular devices market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

• Diagnostic & Monitoring Devices (Ecg, Holter Monitors, Event Monitors, Implantable Loop Recorders, Echocardiogram, Pet Scan, Mri, Cardiac Ct, Doppler Fetal Monitors, Cardiac Diagnostic Catheters)
• Surgical Devices (Pacemakers, Stents, Catheters & Accessories, Guidewires, Cannulae, Electrosurgical Procedures, Valves, Occlusion Devices)

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Cardiovascular Devices market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Cardiovascular Devices market include Abbott, GE HealthCare, Edwards Lifesciences Corporation, W. L. Gore & Associates, Inc., Siemens Healthcare GmbH, BIOTRONIK SE & Co. KG, Canon Medical Systems Asia Pte. Ltd., B. Braun SE, LivaNova PLC, Cardinal Health, Medtronic, Boston Scientific Corporation. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . CARDIOVASCULAR DEVICES - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product
  • 3.7.2 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL CARDIOVASCULAR DEVICES MARKET ANALYSIS BY PRODUCT

• 5.1 Overview by Product
• 5.2 Historical and Forecast Data
• 5.3 Analysis by Product
• 5.4 Diagnostic & Monitoring Devices (ECG, Holter Monitors, Event Monitors, Implantable Loop Recorders, Echocardiogram, PET Scan, MRI, Cardiac CT, Doppler Fetal Monitors, Cardiac Diagnostic Catheters) Historic and Forecast Sales by Regions
• 5.5 Surgical Devices (Pacemakers, Stents, Catheters & Accessories, Guidewires, Cannulae, Electrosurgical Procedures, Valves, Occlusion Devices) Historic and Forecast Sales by Regions

6 . GLOBAL CARDIOVASCULAR DEVICES MARKET ANALYSIS BY GEOGRAPHY

• 6.1. Regional Outlook
• 6.2. Introduction
• 6.3. North America Sales Analysis
  • 6.3.1. Overview, Historic and Forecast Data Sales Analysis
  • 6.3.2. North America By Segment Sales Analysis
  • 6.3.3. North America By Country Sales Analysis
  • 6.3.4. United State Sales Analysis
  • 6.3.5. Canada Sales Analysis
  • 6.3.6. Mexico Sales Analysis
• 6.4. Europe Sales Analysis
  • 6.4.1. Overview, Historic and Forecast Data Sales Analysis
  • 6.4.2. Europe by Segment Sales Analysis
  • 6.4.3. Europe by Country Sales Analysis
  • 6.4.4. United Kingdom Sales Analysis
  • 6.4.5. France Sales Analysis
  • 6.4.6. Germany Sales Analysis
  • 6.4.7. Italy Sales Analysis
  • 6.4.8. Russia Sales Analysis
  • 6.4.9. Rest Of Europe Sales Analysis
• 6.5. Asia Pacific Sales Analysis
  • 6.5.1. Overview, Historic and Forecast Data Sales Analysis
  • 6.5.2. Asia Pacific by Segment Sales Analysis
  • 6.5.3. Asia Pacific by Country Sales Analysis
  • 6.5.4. China Sales Analysis
  • 6.5.5. India Sales Analysis
  • 6.5.6. Japan Sales Analysis
  • 6.5.7. South Korea Sales Analysis
  • 6.5.8. Australia Sales Analysis
  • 6.5.9. South East Asia Sales Analysis
  • 6.5.10. Rest Of Asia Pacific Sales Analysis
• 6.6. Latin America Sales Analysis
  • 6.6.1. Overview, Historic and Forecast Data Sales Analysis
  • 6.6.2. Latin America by Segment Sales Analysis
  • 6.6.3. Latin America by Country Sales Analysis
  • 6.6.4. Brazil Sales Analysis
  • 6.6.5. Argentina Sales Analysis
  • 6.6.6. Peru Sales Analysis
  • 6.6.7. Chile Sales Analysis
  • 6.6.8. Rest of Latin America Sales Analysis
• 6.7. Middle East & Africa Sales Analysis
  • 6.7.1. Overview, Historic and Forecast Data Sales Analysis
  • 6.7.2. Middle East & Africa by Segment Sales Analysis
  • 6.7.3. Middle East & Africa by Country Sales Analysis
  • 6.7.4. Saudi Arabia Sales Analysis
  • 6.7.5. UAE Sales Analysis
  • 6.7.6. Israel Sales Analysis
  • 6.7.7. South Africa Sales Analysis
  • 6.7.8. Rest Of Middle East And Africa Sales Analysis

7 . COMPETITIVE LANDSCAPE OF THE CARDIOVASCULAR DEVICES COMPANIES

• 7.1. Cardiovascular Devices Market Competition
• 7.2. Partnership/Collaboration/Agreement
• 7.3. Merger And Acquisitions
• 7.4. New Product Launch
• 7.5. Other Developments

8 . COMPANY PROFILES OF CARDIOVASCULAR DEVICES INDUSTRY

• 8.1. Company Share Analysis
• 8.2. Market Concentration Rate
• 8.3. Abbott
  • 8.3.1. Company Overview
  • 8.3.2. Company Revenue
  • 8.3.3. Products
  • 8.3.4. Recent Developments
• 8.4. GE HealthCare
  • 8.4.1. Company Overview
  • 8.4.2. Company Revenue
  • 8.4.3. Products
  • 8.4.4. Recent Developments
• 8.5. Edwards Lifesciences Corporation
  • 8.5.1. Company Overview
  • 8.5.2. Company Revenue
  • 8.5.3. Products
  • 8.5.4. Recent Developments
• 8.6. W. L. Gore & Associates Inc.
  • 8.6.1. Company Overview
  • 8.6.2. Company Revenue
  • 8.6.3. Products
  • 8.6.4. Recent Developments
• 8.7. Siemens Healthcare GmbH
  • 8.7.1. Company Overview
  • 8.7.2. Company Revenue
  • 8.7.3. Products
  • 8.7.4. Recent Developments
• 8.8. BIOTRONIK SE & Co. KG
  • 8.8.1. Company Overview
  • 8.8.2. Company Revenue
  • 8.8.3. Products
  • 8.8.4. Recent Developments
• 8.9. Canon Medical Systems Asia Pte. Ltd.
  • 8.9.1. Company Overview
  • 8.9.2. Company Revenue
  • 8.9.3. Products
  • 8.9.4. Recent Developments
• 8.10. B. Braun SE
  • 8.10.1. Company Overview
  • 8.10.2. Company Revenue
  • 8.10.3. Products
  • 8.10.4. Recent Developments
• 8.11. LivaNova PLC
  • 8.11.1. Company Overview
  • 8.11.2. Company Revenue
  • 8.11.3. Products
  • 8.11.4. Recent Developments
• 8.12. Cardinal Health
  • 8.12.1. Company Overview
  • 8.12.2. Company Revenue
  • 8.12.3. Products
  • 8.12.4. Recent Developments
• 8.13. Medtronic
  • 8.13.1. Company Overview
  • 8.13.2. Company Revenue
  • 8.13.3. Products
  • 8.13.4. Recent Developments
• 8.14. Boston Scientific Corporation
  • 8.14.1. Company Overview
  • 8.14.2. Company Revenue
  • 8.14.3. Products
  • 8.14.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies